Bulletin
Investor Alert

New York Markets Open in:

SQZ Biotechnologies Co.

NYS: SQZ

GO
/marketstate/country/us

Before the Bell

 --Real time quotes

May 27, 2022, 8:00 a.m.

SQZ
/zigman2/quotes/222210446/composite

$

3.45

Change

0.00 0.00%

Volume

Volume 2

Real time quotes

/zigman2/quotes/222210446/composite

Previous close

$ 3.45

$ 3.45

Change

+0.10 +2.99%

Day low

Day high

$3.31

$3.58

Open

52 week low

52 week high

$2.73

$16.17

Open

Amy L. Schulman

Amy L. Schulman is a businessperson who founded Lyndra Therapeutics, Inc. and Suono Bio, Inc. and who has been at the head of 7 different companies. Ms. Schulman is Chairman at SQZ Biotechnologies Co., Co-Executive Chairman at Lyndra Therapeutics, Inc. and Partner at Polaris Growth Management LLC. Ms. Schulman is also Member of The Brookings Institution and on the board of 17 other companies.

She previously was Executive Chairman at Suono Bio, Inc., President & General Manager at Nutrition, Inc., President-Vaccines, Oncology & Consumer Healthcare at Pfizer Inc. Executive Vice President & General Counsel of Wyeth Corp. and Executive Vice President & General Counsel for Pfizer Consumer Healthcare (both are subsidiaries of Pfizer Inc.), Executive Chairman & Chief Executive Officer for Olivo Laboratories LLC, Chief Executive Officer for Eagle Biologics, Inc., President at Pfizer Nutrition and Partner at Advokatfirma DLA Piper Sweden AB.

Amy L. Schulman received an undergraduate degree from Wesleyan University and a graduate degree from Yale Law School.

Transactions

Date Shares Transaction Value
12/13/2021 1,850   Acquisition at $10.94 per share. 20,239
12/13/2021 1,850   Acquisition at $10.88 per share. 20,128
11/03/2020 11,025   Derivative/Non-derivative trans. at $0 per share. 0

Officers and Executives

Ms. Amy L. Schulman
Chairman
Dr. Armon Sharei
President, CEO, CFO & Director
Dr. Howard Bernstein
Chief Scientific Officer
Mr. Micah Zajic
Chief Business Officer
Dr. Jonathan Gilbert
Vice President-Exploratory
Dr. Ricardo Zwirtes
Vice President-Clinical Development
Ms. Kyle Feldman
Talent Partner
Mr. Richard Capasso
Chief Accounting Officer
Mr. Michael Kaiser
Investor Relations Contact
Mr. David First
Chief People Officer
Mr. Lawrence J. Knopf
General Counsel
Mr. Andrew Elnatan
Vice President-Regulatory Affairs
Dr. Paul B. Bolno
Independent Director
Dr. Sapna R. Srivastava
Independent Director
Dr. Marc Schegerin
Independent Director
Dr. Bernard Coulie
Independent Director
Dr. Patrick Volkert Vink
Independent Director
Dr. Klavis F. Jensen
Independent Director
Mr. Marc W. Elia
Independent Director
Dr. Pushkal P. Garg
Independent Director
Link to MarketWatch's Slice.